Impact of chronic obstructive pulmonary disease in patients undergoing coronary artery bypass graft surgery
https://doi.org/10.36604/1998-5029-2021-81-126-134
Abstract
Introduction. Cardiovascular disease is the leading cause of morbidity, disability and mortality in modern society. Coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) are the most common comorbid pathology that worsens the quality of life and prospective prognosis of patients.
Aim. The literature review is focused on postoperative outcomes of patients with COPD undergoing coronary artery bypass grafting surgery (CABG).
Results. The review presents national and international data the prevalence of COPD in patients having CABG. The issues of risk stratification of comorbid patients in cardiac surgery are considered. It is shown that patients with CAD in combination with COPD are more at risk of various complications after CABG. COPD increases the chances of a complicated course of the in-hospital period by 2.1 times and risk of death in the long-term period after CAPG by 1.8 times. Patients with COPD are at a higher risk of developing postoperative pneumonia, respiratory failure, stroke, kidney failure, and wound infection of the sternum. Long-term 5-year and 10-year survival after CABG is lower in patients with COPD. The longterm adverse prognosis depends on the severity of the bronchial obstruction. Achievements in the field of cardiac surgery have had a significant impact on the results of surgical interventions in the comorbid course of CAD and COPD. Intensive pulmonary rehabilitation after surgery and effective drug therapy can improve the outcomes after CABG in patients with COPD. Hybrid coronary revascularization and minimally invasive coronary surgery appear to be viable alternatives to conventional CABG, offering a less invasive approach to coronary revascularization, which may be especially beneficial to high-risk patients with COPD.
About the Authors
O. V. Atamas
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment; Far Eastern Federal University, Medical Center
Russian Federation
Russian Federation
Olga V.Atamas - MD, Postgraduate Student, Laboratory of Rehabilitative Treatment.
73g Russkaya Str., Vladivostok, 690105; 10 Ajax Bay, Building 25, Russky Island, Primorsky Krai, 690922
M. V. Antonyuk
Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment
Russian Federation
Russian Federation
Marina V. Antonyuk - MD, PhD, DSc (Med.), Рrofessor, Head of Laboratory of Rehabilitative Treatment.
73g Russkaya Str., Vladivostok, 690105
References
1. Efros LA, Samorodskaya I.V. Features of the structure and the impact of comorbidities on the long-term prognosis after coronary bypass grafting. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya» (Bulletin of Bakoulev Center Cardiovascular Diseases) 2013; 14(1):33–41 (in Russian).
2. Barbarash N.L., Semjonov V.Yu., Samorodskaya I.V., Evseeva М.V., Rozhkov N.A., Sumin A.N., Barbarash L.S. Comorbidity in coronary heart disease patients undergoing bypass grafting: an experience of two surgery centers. Russian Journal of Cardiology 2017; (3):6–13 (in Russian). doi: 10.15829/1560-4071-2017-3-6-13
3. Adelborg K., Horváth-Puhó E., Schmidt M., Munch T., Pedersen L., Nielsen P. H., Bøtker H.E., Sørensen H. T. Thirty-year mortality after coronary artery bypass graft surgery: A Danish Nationwide Population-Based Cohort Study. Circ. Cardiovasc. Qual. Outcomes 2017; (10):e002708. doi: 10.1161/CIRCOUTCOMES.116.002708
4. Zhao H., Li L., Yang G., Gong J., Ye L., Zhi S., Zhang X., Li J. Postoperative outcomes of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting surgery. Journal Medicine (Baltimore) 2019; 98(6):e14388. doi: 10.1097/MD.0000000000014388
5. McNeely C., Markwell S., Vassileva C. Trends in patient characteristics and outcomes of coronary artery bypass grafting in the 2000 to 2012 Medicare Population. Ann. Thorac. Surg. 2016; 102(1):132–138. doi: 10.1016/j.athoracsur.2016.01.016
6. Leavitt B.J., Ross C.S., Spence B., Surgenor S.D., Olmstead E.M., Clough R. A., Charlesworth D.C., Kramer R.S., O'Connor G.T. Long-Term Survival of Patients With Chronic Obstructive Pulmonary Disease Undergoing Coronary Artery Bypass Surgery. Circulation 2006; (114):430–434. doi: 10.1161/CIRCULATIONAHA.105.000943
7. Konecny T., Somers K., Orban M., Koshino Y., Lennon R.J., Scanlon P.D., Rihal C.S. Interactions between COPD and outcomes after percutaneous coronary intervention. Chest 2010; 138(3):621–627. doi: 10.1378/chest.10-0300
8. Samim D., Tozzi P., Ferrari E. Surgical outcome after isolated on-pump and off-pump anterior descending coronary revascularisation. Swiss Med. Wkly 2015; (28):145: w14239. doi: 10.4414/smw.2015.14239
9. 2018 ESC/EACTS guidelines on myocardial revascularization. Russian Journal of Cardiology 2019; (8):151–226 (in Russian.). https://doi.org/10.15829/1560-4071-2019-8-151-226
10. Hussain S.M., Harky A. Complications of coronary artery bypass grafting. Int. J. Med. Rev. 2019; 6(1):1–5. doi: 10.29252/IJMR-060101
11. Hansen L.S., Hjortdal V.E., Andreasen J.J., Mortensen P.E., Jakobsen C.J. 30-day mortality after coronary artery bypass grafting and valve surgery has greatly improved over the last decade, but the 1-year mortality remains constant. Ann. Cardiac. Anaesth. 2015; 18(2):138–142. doi: 10.4103/0971-9784.154462
12. Fuster R.G., Argudo A.M., Albarova O.G., Sos F.H., López S.C., Codoñer M.B., Miñano J.A., Albarran I.R. Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting. Eur. J. Cardiothoracic Surg. 2006; 29(2):202–209. doi: 10.1016/j.ejcts.2005.11.015
13. Samuels L.E., Kaufman M.S., Morris R.J., Promisloff R., Brockman S.K. Coronary artery bypass grafting in patients with COPD. Chest 1998; 113(4):878–882. doi: 10.1378/chest.113.4.878
14. Saleh H.Z., Mohan K., Shaw M., Al-Rawi O., Elsayed H., Walshaw M., Chalmers J.A., Fabri B.M. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. Eur. J. Cardiothoracic Surg. 2012; 42(1):108–113. doi: 10.1093/ejcts/ezr271
15. Wolman R.L., Nussmeier N.A., Aggarwal A., Kanchuger M.S., Roach G.W., Newman M.F., Mangano C. M., Marschall K.E., Ley C., Boisvert D.M., Ozanne G.M., Herskowitz A., Graham S.H., Mangano D.T. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research and Education Foundation (IREF) Investigators. Stroke 1999; 30(3):514–522. doi: 10.1161/01.str.30.3.514
16. Selim M. Perioperative stroke. N. Engl. J. Med. 2007; 356 (7):706–713. doi: 10.1056/NEJMra062668
17. Klinkova A.S., Kamenskaya O.v., Karaskov A.M. Influence of the chronic obstructive pulmonary disease on postoperation course in coronary heart disease. Rossiiskii kardiologicheskii zhurnal = Russian Journal of Cardiology 2016; (4):64–69 (in Russian). doi: 10.15829/1560-4071-2016-4-64-69
18. Roche R.J., Farmery A.D., Garrard C.S. Outcome for cardiothoracic surgical patients requiring multidisciplinary intensive care. Eur. J. Anaesthesiol. 2003; 20(3):719–725. doi: 10.1017/s0265021503001169
19. Sef D., Szavits-Nossan J., Predrijevac M., Golubic R., Sipić T., Stambuk K., Meier P. Management of perioperative myocardial ischaemia after isolated coronary artery bypass graft surgery. Open Heart 2019; 6(1):e001027. doi: 10.1136/openhrt-2019-001027
20. Zafiraki V.K., Skaletckii K.V., Stavenchuk T.V., Kosmachova E.D. In patients with stable angina pectoris and chronic obstructive pulmonary disease undergoing coronary artery bypass grafting surgery. Kuban Scientific Medical Bulletin 2014; (3):49–53 (in Russian). doi: 10.25207/1608-6228-2014-3-49-53
21. Steinberg B.A., Zhao Y., He X., Hernandez A.F., Fullerton D.A., Thomas K.L., Mills R., Klaskala W., Peterson E.D., Piccini J.P. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: Insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin. Cardiol. 2014; 37(1):7–13. doi: 10.1002/clc.22230
22. Rouhi-Boroujeni H., Rouhi-Boroujeni H., Rouhi-Boroujeni P., Sedehi M. Long-term pulmonary functional status following coronary artery bypass grafting surgery. ARYA Atheroscler. 2015; 11(2):163–166.
23. Mariscalco G., Biancari F., Zanobini M., Cottini M., Piffaretti G., Saccocci M., Banach M., Beghi C., Angelini G.D. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. Am. Heart Assoc. 2014; 3(2):e000752. doi: 10.1161/JAHA.113.000752
24. Lin M.H., Kamel H., Singer D. E., Wu Y.L., Lee M., Ovbiagele B. Perioperative/Postoperative. Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality. A Meta-Analysis. Stroke 2019; 50(6):1364–1371. doi: 10.1161/STROKEAHA.118.023921Stroke
25. Welsby I.J., Bennett-Guerrero E., Atwell D., White W.D., Newman M.F., Smith P.K., Mythen M.G. The association of complication type with mortality and prolonged stay after cardiac surgery with cardiopulmonary bypass. Anesth. Analg. 2002; 94(5):1072–1078. doi: 10.1097/00000539-200205000-00004
26. Sprindzhuk M.V., Adzerikho I.E., Lapteva I.M., Dergachev A.V. Bronchopulmonary complications in cardiac surgery. Novosti khirurgii 2008; 16(2):149–157 (in Russian).
27. Mack M.J., Brown P.P., Kugelmass A.D. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann. Thorac. Surg. 2004; 77(3):761–768. doi: 10.1016/j.athoracsur.2003.06.019
28. Efird J.T., Griffin W., O'Neal W.T., Davies S.W., Shiue K.Y., Grzybowski M., Kindell L.C., Kypson A.P., Bowling M., Ferguson T.B., Alger L., Crane. P.B. Long-term survival after cardiac surgery in patients with chronic obstructive pulmonary disease. Am. J. Crit. Care 2016; 25(3):266–276. doi. 10.4037/ajcc2016119
29. Rhee K.Y., Sung T.Y., Kim J.D., Kang H., Mohamad N., Kim T.Y. High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study. Int. Med. Res. 2018; 46(3):1238–1248. doi: 10.1177/0300060517746841
30. Bazdyrev E.D. Dysfunction of respiratory system in patients with coronary artery disease after planned coronary artery bypass grafting. Complex Issues of Cardiovascular Diseases 2017; (2):65–78 (in Russian). doi: 10.17802/2306-1278-2017-2-65-78
31. Bazdyrev E.D., Polikutina O.M., Kalichenko N.A., Slepinina Yu.S., Barbarash O.L. Cardiorespiratory complications after coronary artery bypass grafting. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery 2017; 21(2):85–97 (in Russian). doi: 10.21688-1681-3472-2017-2-85-97
32. Angouras D. C., Anagnostopoulos C. E., Chamogeorgakis T.P., Rokkas C.K.,. Swistel D.G, Connery C.P., Toumpoulis I.K. Postoperative and long-term outcome of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting. Ann. Thorac. Surg. 2010; 89(4):1112–1118. doi: 10.1016/j.athoracsur.2010.01.009
33. Zafiraki V.K., Skaletsky K.V., Kosmacheva E.D., Shulzhenko L.V., Ramazanov J.M., Omarov A.A. Myocardial revascularization in patients with chronic ischemic heart disease combined with chronic obstructive pulmonary disease. Kardiologiia 2016; 56(1):51–55 (in Russian). doi: 10.18565/cardio.2016.1.51-55
34. Wannamethee S.G., Shaper A.G., Papacosta O., Lennon L., Welsh P., Whincup P.H. Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart Study. Thorax 2016; 71(6):526–534. doi: 10.1136/thoraxjnl-2014-206724
35. Rady M.Y., Ryan T.A., Starr N.J. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit. Care Med. 1998; 26(2):225–235. doi: 10.1097/00003246-199802000-00016
36. Güler M., Kirali K., Toker M.E., Bozbuğa N., Omeroğlu S.N., Akinci E., Yakut C. Different CABG methods in patients with chronic obstructive pulmonary disease. Ann. Thorac. Surg. 2001; 71(1):152–157. doi: 10.1016/S0003-4975(00)02250-5
37. DeRose Jr J.J., Toumpoulis I.K., Balaram S.K., Ioannidis J.P., Belsley S., Ashton Jr R.C., Swistel D.G., Anagnostopoulos C.E. Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. Thorac. Cardiovasc. Surg. 2005; 129(2):314–321. doi: 10.1016/j.jtcvs.2004.05.022
38. Medalion B., Katz M.G., Cohen A.J., Hauptman E., Sasson L., Schachner A. Long-term beneficial effect of coronary artery bypass grafting in patients with COPD. Chest 2004; 125 (1):56–62. doi: 10.1378/chest.125.1.56
39. Efird J.T., O’Neal W.T., Anderson C.A., O’Neal J.B., Kindell L.C., Ferguson T.B., Chitwood R.W., Kypson A.P. The effect of race and chronic obstructive pulmonary disease on long-term survival after coronary artery bypass grafting. Front. Public Health 2013; 1(4):1–7. doi: 10.3389/fpubh.2013.00004
40. O'Boyle F., Mediratta N., Chalmers J., Al-Rawi O., Mohan K. , Shaw M., Poullis M. Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery. Eur. J. Cardiothoracic Surg. 2013; 43(4):697–703. doi: 10.1093/ejcts/ezs454
Review
For citations:
Atamas O.V., Antonyuk M.V. Impact of chronic obstructive pulmonary disease in patients undergoing coronary artery bypass graft surgery. Bulletin Physiology and Pathology of Respiration. 2021;(81):126-134. (In Russ.) https://doi.org/10.36604/1998-5029-2021-81-126-134
Views:
906
Email this article 